Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Dear Members, The annual conference of the International Society of Biofabrication ISBF is being held this September 17-20 in Saskatoon, Saskatchewan...

Dear Members, The early bird registration deadline for CBS 2023 in Halifax has been extended to April 21st, 2023 To register, click here...

Dear Members, The abstract submission deadline for CBS 2023 in Halifax has been extended to March 17th, 2023 Please click here to learn more...

The Exploration of Biomat-X EBMX invites you to submit your next original contribution to the inaugural edition of this journal to help the journal positioning itself among the major players in the field...

Arterial bypass graft is the primary therapy for patients with advanced vascular occlusion diseases and, in recent years, the development of tissue-engineered vascular grafts has emerged as a promising, clinically applicable alternative to autografts...

In recent years, the development of multiplexing assays collecting multiple endpoints from one single sample has increased in a number of fields including toxicology and drug development ...

We have used a biomaterial to release anti-inflammatory compounds to improve the biocompatibility of implanted devices...

Injectable hydrogels that can be delivered using needles offer particular advantages in biomedical applications given that these hydrogels do not require invasive surgical implantation, thereby reducing recovery time for patients, reducing costs, and in many cases enabling direct encapsulation, rather than post-encapsulation, of cells during the gel formation process 1 ...

Vascular tissue engineering seeks to produce biologically and mechanically responsive vascular substitutes using cells, scaffolds and bioreactors, to address the shortcomings of current vascular interventions such as coronary artery bypass grafts and to create pre-clinical testing platforms to study vascular pathologies...